Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,644 public trials 847 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Recruiting

Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

NCT07197307

Conditions
Aggressive Diffuse Large B-cell Lymphoma, Follicular Lymphoma (FL) Grade 3B, Hemic and Lymphatic Diseases, +12 more
Locations
  • Universitätsklinikum Münster, Medizinische Klinik A Münster, Germany
  • Universitaetsklinikum Aachen Aachen, Germany
  • Universitaetsklinikum Augsburg Augsburg, Germany
  • Vivantes Netzwerk fuer Gesundheit Berlin, Germany
View all 34 locations
View Trial Details
Recruiting

Long-term Follow up Local Registry Study of Kymriah in South Korea

NCT06785818

Conditions
B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +17 more
Locations
  • Novartis Investigative Site Bundang Gu, Gyeonggi-do, South Korea
  • Novartis Investigative Site Seongnam-si, Gyeonggi-do, South Korea
  • Novartis Investigative Site Gyeonggi-do, Korea, South Korea
  • Novartis Investigative Site Incheon, Korea, South Korea
View all 18 locations
View Trial Details
Recruiting

Personalized NK Cell Therapy in CBT

NCT02727803

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, +55 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study of ARC-02 in B-cell NHL

NCT07691606

Conditions
B-cell Non Hodgkin Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +21 more
Locations
  • Start Cala Los Angeles, California, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • NYU Langone New York, United States
  • Levine Cancer Institute Charlotte, North Carolina, United States
View all 29 locations
View Trial Details
Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

NCT06124157

Conditions
B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 155 locations
View Trial Details
Recruiting

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

NCT07020533

Conditions
Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +38 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Northside Hospital Atlanta, Georgia, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

NCT06150664

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +37 more
Locations
  • D&H Cancer Research Center Margate, Florida, United States
  • Florida Cancer Specialists - Lake Nona Orlando, Florida, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • University Cancer & Blood Center Athens, Georgia, United States
View Trial Details

Related conditions